Brief: Lunai Bioworks Executes $20M Strategic Transaction At Fixed $1.50 Conversion, Acquiring Bbb Delivery Platform For Cns Alzheimer's Therapies With Broad Cns Delivery Applications
26/03/2026 12:52
Lunai Bioworks Inc LNAI.O: LUNAI BIOWORKS EXECUTES $20M STRATEGIC TRANSACTION AT FIXED $1.50 CONVERSION, ACQUIRING BBB DELIVERY PLATFORM FOR CNS ALZHEIMER'S THERAPIES WITH BROAD CNS DELIVERY APPLICATIONS Source text: ID:nPn9jWs8Fa Further company coverage: LNAI.O
Recent news on Lunai Bioworks
See all newsNASDAQ RESUMED AT 02:16 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:06 PM
Brief: Lunai Bioworks Expands Parkinson's Platform Through Exclusive Tanaist Agreement
Brief: Lunai Bioworks Signs Agreement With Brainstorm Therapeutics
Brief: Lunai Bioworks - Regains Nasdaq Compliance With Minimum $1 Bid Price Rule - SEC Filing